Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors

Priestley, E. Scott; Cheney, Daniel L.; DeLucca, Indawati; Wei, Anzhi; Luettgen, Joseph M.; Rendina, Alan R.; Wong, Pancras C.; Wexler, Ruth R.

doi:10.1021/acs.jmedchem.5b00788

Title: Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors

Journal Article · Tue Jul 07 00:00:00 EDT 2015 · Journal of Medicinal Chemistry

DOI:https://doi.org/10.1021/acs.jmedchem.5b00788· OSTI ID:1347770

Priestley, E. Scott ^[1]; Cheney, Daniel L. ^[1]; DeLucca, Indawati ^[1]; Wei, Anzhi ^[1]; Luettgen, Joseph M. ^[1]; Rendina, Alan R. ^[1]; Wong, Pancras C. ^[1]; Wexler, Ruth R. ^[1]

Bristol-Myers Squibb Research & Development, Pennington, NJ (United States)

On the basis of a crystal structure of a phenylpyrrolidine lead and subsequent molecular modeling results, we designed and synthesized a novel series of macrocyclic FVIIa inhibitors. Here, the optimal 16-membered macrocycle was 60-fold more potent than an acyclic analog. Further potency optimization by incorporation of P1' alkyl sulfone and P2 methyl groups provided a macrocycle with TF/FVIIa K_i = 1.6 nM, excellent selectivity against a panel of seven serine proteases, and FVII-deficient prothrombin time EC_2x = 1.2 μM. Discovery of this potent, selective macrocyclic scaffold opens new possibilities for the development of orally bioavailable FVIIa inhibitors.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States)

Sponsoring Organization:: USDOE

OSTI ID:: 1347770

Journal Information:: Journal of Medicinal Chemistry, Vol. 58, Issue 15; ISSN 0022-2623

Publisher:: American Chemical Society (ACS)Copyright Statement

Country of Publication:: United States

Language:: ENGLISH

Citation Metrics:

Cited by: 25 works

Citation information provided by
Web of Science

References (68)

Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis Mackman, Nigel; Tilley, Rachel E.; Key, Nigel S. Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Issue 8 https://doi.org/10.1161/ATVBAHA.107.141911	journal	August 2007
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor Banner, David W.; D'Arcy, Allan; Chène, Christiana Nature, Vol. 380, Issue 6569 https://doi.org/10.1038/380041a0	journal	March 1996
Antithrombotic and Antilesion Benefits without Hemorrhagic Risks by Inhibiting Tissue Factor Pathway Harker, Laurence A.; Hanson, Stephen R.; Wilcox, Josiah N. Pathophysiology of Haemostasis and Thrombosis, Vol. 26, Issue 1 https://doi.org/10.1159/000217245	journal	January 1996
Antithrombotic Effects of Recombinant Human, Active Site–Blocked Factor VIIa in a Rabbit Model of Recurrent Arterial Thrombosis Golino, Paolo; Ragni, Massimo; Cirillo, Plinio Circulation Research, Vol. 82, Issue 1 https://doi.org/10.1161/01.RES.82.1.39	journal	January 1998
Pharmacological Interruption of Acute Thrombus Formation with Minimal Hemorrhagic Complications by a Small Molecule Tissue Factor/Factor VIIa Inhibitor: Comparison to Factor Xa and Thrombin Inhibition in a Nonhuman Primate Thrombosis Model Suleymanov, Osman D.; Szalony, James A.; Salyers, Anita K. Journal of Pharmacology and Experimental Therapeutics, Vol. 306, Issue 3 https://doi.org/10.1124/jpet.103.052779	journal	June 2003
Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time Szalony, James A.; Suleymanov, Osman D.; Salyers, Anita K. Thrombosis Research, Vol. 112, Issue 3 https://doi.org/10.1016/j.thromres.2003.10.017	journal	January 2003
Assessment of Bleeding Propensity in Non-Human Primates by Combination of Selective Tissue Factor/VIIa Inhibition and Aspirin Compared to Warfarin and Aspirin Treatment Salyers, Anita K.; Szalony, James A.; Suleymanov, Osman D. Pharmacology, Vol. 70, Issue 2 https://doi.org/10.1159/000074674	journal	January 2004
A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo Olivero, Alan G.; Eigenbrot, Charles; Goldsmith, Richard Journal of Biological Chemistry, Vol. 280, Issue 10 https://doi.org/10.1074/jbc.M409068200	journal	March 2005
Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model Young, Wendy B.; Mordenti, Joyce; Torkelson, Steven Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 7 https://doi.org/10.1016/j.bmcl.2005.12.059	journal	April 2006
Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity Zbinden, Katrin Groebke; Banner, David W.; Hilpert, Kurt Bioorganic & Medicinal Chemistry, Vol. 14, Issue 15 https://doi.org/10.1016/j.bmc.2006.03.042	journal	August 2006
The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor Arnold, C. Shane; Parker, Cynthia; Upshaw, Ramanda Thrombosis Research, Vol. 117, Issue 3 https://doi.org/10.1016/j.thromres.2005.03.015	journal	January 2006
BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies Wong, Pancras; Luettgen, Joseph; Rendina, Alan Thrombosis and Haemostasis, Vol. 104, Issue 08 https://doi.org/10.1160/TH10-01-0025	journal	January 2010
Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement Lee, Agnes; Agnelli, Giancarlo; Büller, Harry Circulation, Vol. 104, Issue 1 https://doi.org/10.1161/hc2601.091386	journal	July 2001
Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplastyAppendix Moons, Arno H. M.; Peters, Ron J. G.; Bijsterveld, Nick R. Journal of the American College of Cardiology, Vol. 41, Issue 12 https://doi.org/10.1016/S0735-1097(03)00478-9	journal	June 2003
Recombinant Nematode Anticoagulant Protein c2 in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Giugliano, Robert P.; Wiviott, Stephen D.; Stone, Peter H. Journal of the American College of Cardiology, Vol. 49, Issue 25 https://doi.org/10.1016/j.jacc.2007.02.065	journal	June 2007
Optimization of a screening lead for factor VIIa/TF Young, Wendy B.; Kolesnikov, Aleksandr; Rai, Roopa Bioorganic & Medicinal Chemistry Letters, Vol. 11, Issue 17 https://doi.org/10.1016/S0960-894X(01)00420-6	journal	September 2001
Factor VIIa inhibitors: A prodrug strategy to improve oral bioavailability Riggs, Jennifer R.; Kolesnikov, Aleksandr; Hendrix, John Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 8 https://doi.org/10.1016/j.bmcl.2006.01.039	journal	April 2006
Factor VIIa inhibitors: Improved pharmacokinetic parameters Kolesnikov, Aleksandr; Rai, Roopa; Young, Wendy B. Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 8 https://doi.org/10.1016/j.bmcl.2006.01.037	journal	April 2006
Discovery of novel heterocyclic factor VIIa inhibitors Rai, Roopa; Kolesnikov, Aleksandr; Sprengeler, Paul A. Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 8 https://doi.org/10.1016/j.bmcl.2006.01.017	journal	April 2006
Novel 5-azaindole factor VIIa inhibitors Riggs, Jennifer R.; Hu, Huiyong; Kolesnikov, Aleksandr Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 12 https://doi.org/10.1016/j.bmcl.2006.03.049	journal	June 2006
Efforts toward oral bioavailability in factor VIIa inhibitors Vijaykumar, Dange; Rai, Roopa; Shaghafi, Michael Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 14 https://doi.org/10.1016/j.bmcl.2006.04.018	journal	July 2006
Potent 4-amino-5-azaindole factor VIIa inhibitors Hu, Huiyong; Kolesnikov, Aleksandr; Riggs, Jennifer R. Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 17 https://doi.org/10.1016/j.bmcl.2006.06.016	journal	September 2006
Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors Groebke Zbinden, Katrin; Banner, David W.; Ackermann, Jean Bioorganic & Medicinal Chemistry Letters, Vol. 15, Issue 3 https://doi.org/10.1016/j.bmcl.2004.10.092	journal	February 2005
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors Zbinden, Katrin Groebke; Obst-Sander, Ulrike; Hilpert, Kurt Bioorganic & Medicinal Chemistry Letters, Vol. 15, Issue 23 https://doi.org/10.1016/j.bmcl.2005.04.079	journal	December 2005
Nonbenzamidine acylsulfonamide tissue factor–factor VIIa inhibitors Glunz, Peter W.; Zhang, Xiaojun; Zou, Yan Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 18 https://doi.org/10.1016/j.bmcl.2013.06.027	journal	September 2013
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors Zhang, Xiaojun; Jiang, Wen; Jacutin-Porte, Swanee ACS Medicinal Chemistry Letters, Vol. 5, Issue 2 https://doi.org/10.1021/ml400453z	journal	December 2013
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex South, Michael S.; Case, Brenda L.; Wood, Rhonda S. Bioorganic & Medicinal Chemistry Letters, Vol. 13, Issue 14 https://doi.org/10.1016/S0960-894X(03)00410-4	journal	July 2003
Design, Parallel Synthesis, and Crystal Structures of Pyrazinone Antithrombotics as Selective Inhibitors of the Tissue Factor VIIa Complex Parlow, John J.; Case, Brenda L.; Dice, Thomas A. Journal of Medicinal Chemistry, Vol. 46, Issue 19 https://doi.org/10.1021/jm030131l	journal	September 2003
Design, Synthesis, and Crystal Structure of Selective 2-Pyridone Tissue Factor VIIa Inhibitors Parlow, John J.; Kurumbail, Ravi G.; Stegeman, Roderick A. Journal of Medicinal Chemistry, Vol. 46, Issue 22 https://doi.org/10.1021/jm0301686	journal	September 2003
Structure-based design and synthesis of pyrazinones containing novel P1 ‘side pocket’ moieties as inhibitors of TF/VIIa Schweitzer, Barbara A.; Neumann, William L.; Rahman, Hayat K. Bioorganic & Medicinal Chemistry Letters, Vol. 15, Issue 12 https://doi.org/10.1016/j.bmcl.2005.04.037	journal	June 2005
Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors Zhang, Xiaojun; Glunz, Peter W.; Jiang, Wen Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 6 https://doi.org/10.1016/j.bmcl.2013.01.094	journal	March 2013
Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitor Priestley, E. Scott; De Lucca, Indawati; Zhou, Jinglan Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 8 https://doi.org/10.1016/j.bmcl.2013.02.013	journal	April 2013
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex Kohrt, Jeffrey T.; Filipski, Kevin J.; Cody, Wayne L. Bioorganic & Medicinal Chemistry Letters, Vol. 15, Issue 21 https://doi.org/10.1016/j.bmcl.2005.07.059	journal	November 2005
The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2 Kohrt, Jeffrey T.; Filipski, Kevin J.; Cody, Wayne L. Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 4 https://doi.org/10.1016/j.bmcl.2005.10.076	journal	February 2006
Design, synthesis, and structure–activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors Klingler, Otmar; Matter, Hans; Schudok, Manfred Bioorganic & Medicinal Chemistry Letters, Vol. 13, Issue 8 https://doi.org/10.1016/S0960-894X(03)00168-9	journal	April 2003
Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition Klingler, Otmar; Matter, Hans; Schudok, Manfred Bioorganic & Medicinal Chemistry Letters, Vol. 14, Issue 14 https://doi.org/10.1016/j.bmcl.2004.05.006	journal	July 2004
An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)-5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company Kohrt, Jeffrey T.; Filipski, Kevin J.; Rapundalo, Stephen T. Tetrahedron Letters, Vol. 41, Issue 32 https://doi.org/10.1016/S0040-4039(00)01016-9	journal	August 2000
Potent and selective TF/FVIIa inhibitors containing a neutral P1 ligand Miura, Masanori; Seki, Norio; Koike, Takanori Bioorganic & Medicinal Chemistry, Vol. 14, Issue 23 https://doi.org/10.1016/j.bmc.2006.08.010	journal	December 2006
Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands Miura, Masanori; Seki, Norio; Koike, Takanori Bioorganic & Medicinal Chemistry, Vol. 15, Issue 1 https://doi.org/10.1016/j.bmc.2006.09.071	journal	January 2007
Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores Kotian, Pravin L.; Krishnan, Raman; Rowland, Scott Bioorganic & Medicinal Chemistry, Vol. 17, Issue 11 https://doi.org/10.1016/j.bmc.2009.04.013	journal	June 2009
Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold Bolton, Scott A.; Sutton, James C.; Anumula, Rushith Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 18 https://doi.org/10.1016/j.bmcl.2013.06.028	journal	September 2013
Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library☆ Sagi, Kazuyuki; Fujita, Koichi; Sugiki, Masayuki Bioorganic & Medicinal Chemistry, Vol. 13, Issue 5 https://doi.org/10.1016/j.bmc.2004.12.033	journal	March 2005
Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors Glunz, Peter W.; Cheng, Xuhong; Cheney, Daniel L. Bioorganic & Medicinal Chemistry Letters, Vol. 25, Issue 10 https://doi.org/10.1016/j.bmcl.2015.03.062	journal	May 2015
Tissue factor–fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic Priestley, E. Scott Drug Discovery Today, Vol. 19, Issue 9 https://doi.org/10.1016/j.drudis.2014.05.023	journal	September 2014
On the size of the active site in proteases. I. Papain Schechter, Israel; Berger, Arieh Biochemical and Biophysical Research Communications, Vol. 27, Issue 2, p. 157-162 https://doi.org/10.1016/S0006-291X(67)80055-X	journal	April 1967
Discovery of Novel P1 Groups for Coagulation Factor VIIa Inhibition Using Fragment-Based Screening Cheney, Daniel L.; Bozarth, Jeffrey M.; Metzler, William J. Journal of Medicinal Chemistry, Vol. 58, Issue 6 https://doi.org/10.1021/jm501982k	journal	February 2015
The Design and Synthesis of Noncovalent Factor Xa Inhibitors Quan, M.; Wexler, R. Current Topics in Medicinal Chemistry, Vol. 1, Issue 2 https://doi.org/10.2174/1568026013395407	journal	June 2001
Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants Lam, Patrick Y. S.; Clark, Charles G.; Li, Renhua Journal of Medicinal Chemistry, Vol. 46, Issue 21 https://doi.org/10.1021/jm020578e	journal	October 2003
Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties Pinto, Donald J. P.; Galemmo, Robert A.; Quan, Mimi L. Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 21 https://doi.org/10.1016/j.bmcl.2006.08.027	journal	November 2006
Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIa Jackson, Sharon; DeGrado, W.; Dwivedi, A. Journal of the American Chemical Society, Vol. 116, Issue 8 https://doi.org/10.1021/ja00087a007	journal	April 1994
Macrocyclic Amino Carboxylates as Selective MMP-8 Inhibitors Cherney, Robert J.; Wang, Li; Meyer, Dayton T. Journal of Medicinal Chemistry, Vol. 41, Issue 11 https://doi.org/10.1021/jm970850y	journal	May 1998
Relationship of Stereochemical and Skeletal Diversity of Small Molecules to Cellular Measurement Space Kim, Young-kwon; Arai, Midori A.; Arai, Takayoshi Journal of the American Chemical Society, Vol. 126, Issue 45 https://doi.org/10.1021/ja048170p	journal	November 2004
The exploration of macrocycles for drug discovery — an underexploited structural class Driggers, Edward M.; Hale, Stephen P.; Lee, Jinbo Nature Reviews Drug Discovery, Vol. 7, Issue 7 https://doi.org/10.1038/nrd2590	journal	July 2008
Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery Marsault, Eric; Peterson, Mark L. Journal of Medicinal Chemistry, Vol. 54, Issue 7 https://doi.org/10.1021/jm1012374	journal	April 2011
Synthetic Macrocycles in Small-Molecule Drug Discovery Vendeville, Sandrine; Cummings, Maxwell D. Annual Reports in Medicinal Chemistry https://doi.org/10.1016/B978-0-12-417150-3.00023-5	book	September 2013
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties? Giordanetto, Fabrizio; Kihlberg, Jan Journal of Medicinal Chemistry, Vol. 57, Issue 2 https://doi.org/10.1021/jm400887j	journal	September 2013
Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients Macías, Juan; Neukam, Karin; Merchante, Nicolás Expert Opinion on Pharmacotherapy, Vol. 15, Issue 13 https://doi.org/10.1517/14656566.2014.934810	journal	July 2014
A new synthesis of α-arylglycines from aryl boronic acids Petasis, Nicos A.; Goodman, Andrew; Zavialov, Ilia A. Tetrahedron, Vol. 53, Issue 48 https://doi.org/10.1016/S0040-4020(97)01028-4	journal	December 1997
Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio The Journal of Organic Chemistry, Vol. 60, Issue 23, p. 7508-7510 https://doi.org/10.1021/jo00128a024	journal	November 1995
Chiral synthesis via organoboranes. 9. Crystalline chelates from borinic and boronic esters. A simple procedure for upgrading borinates and boronates to materials approaching 100% optical purity Brown, Herbert C.; Prasad, J. V. N. Vara The Journal of Organic Chemistry, Vol. 51, Issue 24 https://doi.org/10.1021/jo00374a007	journal	November 1986
A convenient procedure for the synthesis of 1-tetralone derivatives using a Suzuki coupling-Friedel-Crafts acylation sequence Esteban, Gemma; López-Sánchez, Miguel A.; Martínez, MaEugenia Tetrahedron, Vol. 54, Issue 1-2 https://doi.org/10.1016/S0040-4020(97)10270-8	journal	January 1998
Crystallographic R Factor Refinement by Molecular Dynamics Brunger, A. T.; Kuriyan, J.; Karplus, M. Science, Vol. 235, Issue 4787 https://doi.org/10.1126/science.235.4787.458	journal	January 1987
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
Derivation of class II force fields. VI. Carbohydrate compounds and anomeric effects Hwang, M. -J.; Ni, X.; Waldman, M. Biopolymers, Vol. 45, Issue 6 https://doi.org/10.1002/(SICI)1097-0282(199805)45:6<435::AID-BIP3>3.0.CO;2-Q	journal	May 1998
Derivation of class II force fields: V. Quantum force field for amides, peptides, and related compounds Maple, J. R.; Hwang, M. -J.; Jalkanen, K. J. Journal of Computational Chemistry, Vol. 19, Issue 4 https://doi.org/10.1002/(SICI)1096-987X(199803)19:4<430::AID-JCC5>3.0.CO;2-T	journal	March 1998
Derivation of Class II Force Fields. III. Characterization of a Quantum Force Field for Alkanes Maple, J. R.; Hwang, M. -J.; Stockfisch, T. P. Israel Journal of Chemistry, Vol. 34, Issue 2 https://doi.org/10.1002/ijch.199400025	journal	January 1994
Derivation of Class II Force Fields. 2. Derivation and Characterization of a Class II Force Field, CFF93, for the Alkyl Functional Group and Alkane Molecules Hwang, M. J.; Stockfisch, T. P.; Hagler, A. T. Journal of the American Chemical Society, Vol. 116, Issue 6 https://doi.org/10.1021/ja00085a036	journal	March 1994
Derivation of class II force fields. I. Methodology and quantum force field for the alkyl functional group and alkane molecules Maple, J. R.; Hwang, M. -J.; Stockfisch, T. P. Journal of Computational Chemistry, Vol. 15, Issue 2 https://doi.org/10.1002/jcc.540150207	journal	February 1994

Cited By (6)

Recent advances in the discovery and development of factor XI/XIa inhibitors Al-Horani, Rami A.; Afosah, Daniel K. Medicinal Research Reviews, Vol. 38, Issue 6 https://doi.org/10.1002/med.21503	journal	May 2018
High throughput evaluation of macrocyclization strategies for conformer stabilization Sindhikara, Dan; Borrelli, Ken Scientific Reports, Vol. 8, Issue 1 https://doi.org/10.1038/s41598-018-24766-5	journal	April 2018
Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin Van Lam van, Thuy; Ivanova, Teodora; Hardes, Kornelia ChemMedChem, Vol. 14, Issue 6 https://doi.org/10.1002/cmdc.201800807	journal	February 2019
Computational Macrocyclization: From de novo Macrocycle Generation to Binding Affinity Estimation Wagner, Vincent; Jantz, Linda; Briem, Hans ChemMedChem, Vol. 12, Issue 22 https://doi.org/10.1002/cmdc.201700478	journal	October 2017
Reactivity and Synthetic Applications of Multicomponent Petasis Reactions Wu, Peng; Givskov, Michael; Nielsen, Thomas E. Chemical Reviews, Vol. 119, Issue 20 https://doi.org/10.1021/acs.chemrev.9b00214	journal	August 2019
Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release Xin, Guang; Wei, Zeliang; Ji, Chengjie Scientific Reports, Vol. 6, Issue 1 https://doi.org/10.1038/srep36222	journal	November 2016

Similar Records

Novel Potent Hepatitis C Virus NS3 Serine Protease Inhibitors Derived from Proline-Based Macrocycles

Journal Article · Mon Jun 30 00:00:00 EDT 2008 · J. Med. Chem. · OSTI ID:1347770

Chen, Kevin X; Njoroge, F George; Arasappan, Ashok; +11 more

Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors

Journal Article · Sat Oct 01 00:00:00 EDT 2016 · Bioorganic & Medicinal Chemistry Letters · OSTI ID:1347770

Ladziata, Vladimir (Uladzimir); Glunz, Peter W.; Zou, Yan; +11 more

The M358R variant of α{sub 1}-proteinase inhibitor inhibits coagulation factor VIIa

Journal Article · Fri Feb 12 00:00:00 EST 2016 · Biochemical and Biophysical Research Communications · OSTI ID:1347770

Bhakta, Varsha

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
peptides and proteins
crystal structure
inhibitors
selectivity
macrocycles

Title: Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors

Citation Formats

References (68)

Cited By (6)

Similar Records

Related Subjects